Receptivity to new smokeless tobacco products among test market populations

描述（由申请人提供）：在卷烟销量下降的背景下，无烟烟草的营销和销售在美国呈上升趋势。目前，美国四家主要的卷烟制造商已经推出了以瑞典鼻烟为蓝本的新型无烟无烟无烟烟草产品，专门针对吸烟者。对这些新的、亚硝胺含量相对较低的无烟烟草制品采取何种适当的公共卫生做法存在相当大的争议。然而，这些产品越来越多的可用性是一个事实，迄今为止，几乎没有关于这些产品使用情况的基于人口的数据。美国国家癌症研究所和美国国家药物滥用研究所发布了一项项目公告，寻求开展研究，以提高人们对使用可能减少暴露的烟草制品的认识，包括开发监测系统和评估使用烟草制品可能伴随的行为变化，如香烟和无烟产品的双重使用。这个应用程序就是针对这些目的的。此时，印第安纳波利斯和达拉斯/Ft。只有在沃斯地区，骆驼鼻烟和万宝路鼻烟这两个主要品牌都能买到。通过有效的双框架抽样方法，本研究将在这些测试市场中对4540名成年人进行基于人口的电话调查，旨在提供证据，证明消费者对新的鼻烟产品的接受程度，吸烟者和非吸烟者尝试产品的比率，要么拒绝它，要么接受它经常使用，以及经常使用对吸烟模式的可能影响。此外，该项目将有助于改进监测措施，并将建立认识、试用和经常使用鼻烟的基准，以及在广告信息、销售战略和（或）产品成分发生变化时可与之进行今后比较的有害观念。通过包括手机补充资料，它将增加对遗漏仅使用手机的家庭如何可能使鼻烟使用估计产生偏差的认识，并建立将手机样本纳入人口调查的能力。最后，如果鼻烟的采用率足够高，值得继续研究，该项目将提供一个可以长期跟踪的受访者小组。

DESCRIPTION (provided by applicant): In the context of declining sales of cigarettes, the marketing and sale of smokeless tobacco is on the rise in the United States. Currently four major U.S. cigarette manufacturers have introduced new spitless, smokeless tobacco products modeled on Swedish snus and targeted specifically to cigarette smokers. There is considerable controversy about the appropriate public health approach to these new, relatively low nitrosamine, smokeless tobacco products. Nevertheless the growing availability of these products is a fact, and to date there is virtually no population-based data on the use of these products. The National Cancer Institute and the National Institute of Drug Abuse have issued a Program announcement seeking research to improve knowledge about the use of potential reduced exposure tobacco products, including developing surveillance systems and assessing behavior changes that may accompany their use such as dual use of cigarettes and smokeless products. This application is directed to those purposes. At this time, Indianapolis and Dallas/Ft. Worth are the only areas where the two major brands, Camel Snus and Marlboro Snus, are both available. By means of an efficient, dual-frame sampling approach, this study will carry out a population-based telephone survey of 4540 adults in those test markets designed to provide evidence of the nature of consumer receptivity to the new snus products, the rate at which smokers and nonsmokers are trying the product and either rejecting it or adopting it for regular use, and the likely impact of regular use on smoking patterns. In addition, the project will contribute to refinement of surveillance measures and will establish benchmarks for awareness, trial and regular use of snus as well as perceptions of harmfulness against which future comparisons can be made as advertising messages, marketing strategies and/or product constituents change. By including a cell phone supplement, it will increase knowledge of how omission of cell phone only households may bias estimates of snus use, and build capacity to integrate cell phone samples into population surveys. Finally, if the rate of snus adoption is high enough to warrant continued study, this project will provide a panel of respondents who can be followed over time. PUBLIC HEALTH RELEVANCE: Low nitrosamine smokeless tobacco products being marketed to cigarette smokers in the U.S. could potentially undermine motivation to quit smoking, and increase the prevalence of tobacco addiction and related disease. On the other hand, they could reduce cigarette consumption which would lower disease risk. This study provides an initial look at how the population of two cities is responding to the products.